LJM1R Stock Overview
Provides health care services in the Republic of Latvia. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
AS Latvijas Juras medicinas centrs Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €6.50 |
52 Week High | €10.10 |
52 Week Low | €5.70 |
Beta | -0.082 |
1 Month Change | -7.14% |
3 Month Change | -7.14% |
1 Year Change | -32.99% |
3 Year Change | -49.22% |
5 Year Change | 51.16% |
Change since IPO | 4,062.66% |
Recent News & Updates
Recent updates
Shareholder Returns
LJM1R | LV Healthcare | LV Market | |
---|---|---|---|
7D | 0% | 0% | 0% |
1Y | -33.0% | 0% | 0% |
Return vs Industry: LJM1R underperformed the LV Healthcare industry which returned 2.2% over the past year.
Return vs Market: LJM1R underperformed the LV Market which returned -11.8% over the past year.
Price Volatility
LJM1R volatility | |
---|---|
LJM1R Average Weekly Movement | 9.5% |
Healthcare Industry Average Movement | 0% |
Market Average Movement | 0% |
10% most volatile stocks in LV Market | 0% |
10% least volatile stocks in LV Market | 0% |
Stable Share Price: LJM1R's share price has been volatile over the past 3 months compared to the LV market.
Volatility Over Time: Insufficient data to determine LJM1R's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 366 | Janis Birks | www.ljmc.lv |
AS Latvijas Juras medicinas centrs provides health care services in the Republic of Latvia. The company engages in the general and special medical practice, dental practice, human health, residential nursing care, residential care, social work, physical well-being, and other personal service activities. It is also involved in provision of other education services related activities.
AS Latvijas Juras medicinas centrs Fundamentals Summary
LJM1R fundamental statistics | |
---|---|
Market cap | €5.28m |
Earnings (TTM) | -€760.42k |
Revenue (TTM) | €10.20m |
0.5x
P/S Ratio-6.9x
P/E RatioIs LJM1R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LJM1R income statement (TTM) | |
---|---|
Revenue | €10.20m |
Cost of Revenue | €9.25m |
Gross Profit | €948.95k |
Other Expenses | €1.71m |
Earnings | -€760.42k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 17, 2025
Earnings per share (EPS) | -0.95 |
Gross Margin | 9.31% |
Net Profit Margin | -7.46% |
Debt/Equity Ratio | 0% |
How did LJM1R perform over the long term?
See historical performance and comparisonDividends
1.5%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 15:10 |
End of Day Share Price | 2024/12/17 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
AS Latvijas Juras medicinas centrs is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|